A synthetic peptide for use as a blocking control in assays to test for specificity of SLC26 A4 antibody, Alternative Names: SLC26A4 control peptide, SLC26A4 antibody Blocking Peptide, Anti-SLC26A4 Blocking Peptide, Solute Carrier Family 26 Member 4 Blocking Peptide, DFNB4 Blocking Peptide, PDS Blocking Peptide, SLC26A4, SLCA4-26, SLCA4 26, SLCA4-26 Blocking Peptide, SLCA4 26 Blocking Peptide
SLC26A4
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SLC26A4
(Solute Carrier Family 26, Member 4 (SLC26A4))
Hintergrund
Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene.